on the HUNT for the Next DIAMOND in the ROUGH
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Michael J. Fox Foundation funded this company
its been under the radar since going public last year....has patents and is way undervalued
AMBS 0064
AMBS 0064 only 110 mil in float 40% owned by insiders
going to a penny plus....jumped to .02 a couple weeks ago
AMBS 006 JV news going to back over a penny+ IMO
AMBS going going...get in !
going back over a penny IMO
AMBS 0062
AMBS 006
AMBS 006
AMBS NEWSBIOTECHbounce off bottom of 005 only 60 mil in float
40 % owned by insiders 1st blood test for early diagnosis of Parkinsons
http://ih.advfn.com/p.php?pid=nmona&article=54433471
AMBS NEWSBIOTECHbounce off bottom of 005 only 60 mil in float
40 % owned by insiders 1st blood test for early diagnosis of Parkinsons
http://ih.advfn.com/p.php?pid=nmona&article=54433471
I love it when my feelings are right
Things around here are going to be looking Very Good in The Near Term
and here is some more $$$
Amarantus BioSciences Receives Grant from Brewer Sports International for Traumatic Brain Injury
SUNNYVALE, CA and MINNEAPOLIS, MN– November 30, 2011 – Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), a first-in-class disease–modifying therapeutic protein, today announced a commitment by Brewer Sports International (BSI) to fund a pre-clinical study evaluating MANF’s potential as a treatment for Traumatic Brain Injury (TBI). This funding will support the collaboration recently announced between Amarantus and Banyan Biomarkers.
I know you know the financing they have in place but here is a review of it if you forgot
Amarantus BioSciences Announces Close of $10M
Equity Funding Facility with Centurion Private
Equity, LLC
SUNNYVALE, CA - October 13, 2011 – Amarantus Biosciences, Inc. (OTCBB: AMBS) a
biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic
protein that addresses an underlying form of cell death known as apoptosis, announced
today that it has closed a $10M Equity Funding Facility with Centurion Private Equity, LLC
(“Centurion”). The Company will have the ability to draw down on this facility over the course
of the next 36 months in tranches of up $750,000
AMBS potential cure for Parkinson disease and TBI which football players suffer from
http://www.amarantus.com 110 mil float 40% owned by insiders
bounce coming off .005- was at .02 couple weeks ago
How is it you have owned this Co. since last year and you know nothing about them? I know you know that this Co. is not known on investors hub B/c you are the poster who has posted the most and that has only been 25o times in just under a year. Don't worry...this will all work out for you
The report also states: "Amarantus owns the license for Power3 Medical Products' NuroPro Blood Test as it relates to Parkinson's disease. NuroPro is a diagnostic platform for the early detection of neurodegenerative diseases. The PD application of this diagnostic has completed proof-of-concept and Phase I clinical validation studies."
http://www.kpho.com/story/19621507/amarantus-biosciences-announces-the-release-of-research-report-by-onemedplace
The report states: "Treatment with MANF prior to inducing PD-like conditions in animals protected the subjects from the onset of neuron degeneration. Even more impressively, in animals where Parkinson's was already present, treatment with MANF provided restorative benefits that included regaining motor function, as well as the maintenance and increase in function of the neurons that were still present. Cumulatively, these studies provide strong evidence that MANF has the potential to serve as a first-in-class curative treatment for degenerative neurological disorders that include PD. Amarantus is currently in the design and development stages to move MANF into clinical trials."
No share exchange but they did get the license rights for Nuropro
Amarantus is on the verge of delivering startling new breakthroughs in the diagnosis and treatment of neurological disorders from Parkinson's disease to Traumatic Brain Injury (TBI). Amarantus owns the rights to a promising therapeutic protein known as MANF that prevents a type of cell death called apoptosis as well as the license to a groundbreaking diagnostic platform called NuroPro that allows neurologists to accurately diagnose and track the progression of Parkinson's disease in patients.
http://www.marketwatch.com/story/rbcc-extends-joint-venture-negotiations-with-amarantus-2012-07-25
Power3, Amarantus sign license agreement for NuroPro Blood Test for Parkinson's
http://www.news-medical.net/news/20120124/Power3-Amarantus-sign-license-agreement-for-NuroPro-Blood-Test-for-Parkinsons.aspx
Ceo also said it in an interview $350 per test
AMBS News 09/26/12 First Penny Picks
Published September 27, 2012
Rainbow Coral Says Projected Market Growth Of Parkinson’s Treatments Promising
(RTTNews.com) – Rainbow Coral Corp.’s (RBCC.OB) or RBCCsaid the current market growth projections for the new treatments for Parkinson’s disease is promising. The company sees a bright outlook as its bio-tech subsidiary Rainbow Biosciences is negotiating a definitive agreement with the emerging biotech innovator Amarantus Biosciences Inc.
As announced by the end of April, RBCC has executed a Letter of Intent to advance Amarantus’s Parkinson’s disease program that include an early detection diagnostic blood test and disease modifying protein drug candidate. Over 6 million patients worldwide are suffering from Parkinson’s disease.
Amarantus owns the rights to MANF, a neurotrophic factor currently in pre-clinical development for the treatment of types of cell deaths called apoptosis. In addition, it owns a license to a diagnostic platform called NuroPro for Parkinson’s that allows neurologists to accurately diagnose and track the progression in patients. The test is expected to be marketed in certain regions by 2013.
RBCC noted that there is a projected growth of $3 billion in Parkinson’s treatment market and the value could grow to $3.75 billion by 2015. According to the Parkinson’s Disease Foundation, there are around one million Americans suffering from Parkinson’s disease, and 60,000 new patients are diagnosed each year. Medication costs are estimated to be around $2,500 per person each year, with a total economic impact of around $25 billion in the U.S. alone.
SUNNYVALE, Calif., Sept. 24, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a California-based development-stage biotechnology developing new treatments and diagnostics for Parkinson's disease (PD) centered around its patented therapeutic protein MANF, today announced the release of a 2-page research report by OneMedPlace Research. The report can be found at http://www.onemedplace.com/reports/Amarantus_Research_Analysis.pdf.
AMBS Michael J. Fox Foundation funded for Parkinson's .005
Low Float 110 Mil. at bottom .005
AMBS Michael J. Fox Foundation funded for Parkinson's .005
Low Float 110 Mil. at bottom .005
It is at a half a penny...for several reasons
You talked about this being pumped by companies that get people to invest while they are unloading. These penny pickers are not into trading or investing they may be issued shares for their advertising and just want to make sure they get paid so they pump the stock with the e-mails sent out while they are selling to their mailing list who was given the impression this was going to 10 to 30 cents. the following day the stock jumps 100 to 200% because of pure emotion that they are going to miss the boat.
Now the penny pickers just want out to get paid so they sell whatever they have left at the low of the stocks history and move on to their next client.
Many of these pump and dumps are just promoting a co. which really has no chance of surviving and they usually go down to 0001. This company actually did a forward split when they did the reverse merger.
A company with a market cap. of 500k with a patent for the treatment of parkinson's and many other neurogical disorders is unheard of-I could be wrong but this is an opportunity of a lifetime if all goes well as it looks like it is.
Once this company starts generating revenue next year it will be 100's or maybe even 1000s of percent higher than where it is now.
This is all IMO of course.
Just look at the news releases over the past year and how everything will be falling into place shortly.
and I want to thank whoever sold me 900,000 shares @ .005
I am excited
It is obvious you know nothing about the Co. We get it-- you bought in at its high for the month and sold out of fear...now time for you to move on- get over it. enough said
100 mil. shares flooding in......even IF that is happenning with 200 mil. outstanding this Co still is WAY UNDERVALUED
Revenues will be coming in in 2013 and with a patented product with numerous studies that it helps with Parkinson's and TBI and many other uses.
Instead of Bashing now you should see the opportunity to buy unless you lost your last couple hundred dollars. If the co. had a A/S of 4 billion shares I would say stay away but the float is very small and with the advertising to get the word out about this Co. and the future that it holds .....IT WILL MOVE UP VERY FAST WITH THE RIGHT NEWS
The Founders are not Scam artist's ......Do your research....just look at the news- nothing but good things to say about them.
Good Luck
all IMO of course
Sorry you had to learn the hard way but you should never let your emotions get involved when you see a stock going up so fast and you feel you are going to miss it or with spam reports....9 times out of ten ....they come back down rather quickly when all the daytraders start exiting....thats when you buy if you believe in the growth a of a company- when everyone else is selling because they are afraid of losing more than half of their investment.
I bought in a small position @ .007
but I bought in pretty significant @ .005 today
I am impressed with this company and the people involved - it is not a shell co. or a scam- there is real potential here and opportuniy
IMO . Have a Great Weekend
RBCC and AMBS down today about 20% with heavy trading....is this a coincidence or do I smell significant news out on Monday?
Amarantus giving Fox, other Parkinsons sufferers new hope
SUNNYVALE, CA – When NBC made a 22-show series commitment in August to actor Michael J. Fox for a series to begin airing in 2013, it was an indication of the new hope for treatment of the Parkinson's disease which forced him from regular series television a dozen years ago.
Dr. John Commissiong presents scientific findings on MANF
Dr. John Commissiong presents scientific findings on MANF
Among the 50 Most Important African-Americans in Technology
One of the big reasons for that hope is a father-son team that created Amarantus BioSciences four years ago
http://www.blackmoney.com/35117
Have we found a support level yet....Its been over a year and a half since i was vested in the co. and she was very good to me. The products are great as i have taken them myself but i feel the only way to turn this around is to do a R/s and get some real investors on board and not just daytraders----this may be a good thing for the co. doing a R/S- Hopefully it will turn around soon- I will be waiting
any idea if the Rock 2 Live fest is still on and when....TY
they aren't ....its just a rule of thumb- sell on the news- I feel this may come down a bit more and then trade sideways until the anticipation of more news to come- Its just daytraders exiting right now -the long term investors will ride this up and down until they get there exit price.
I have moved on to other plays because I love the excitement of daytrading but I need a few days off to get back to business so I bought into some less fluctuating stocks
I would also like to see JV news update
I would like to see it go up....just took a small position @ 007
5 % most of the run up action was when this board was dead
I got in and out twice.....was very fun
I see the risk/ reward is tremendous on the upside.....I also need a break- I have been a green streak but its been very stressful and not easy while running a business.
This is one to hold onto Do you think they will announce Phase 2 results at tomorrow's show? Probably not but it would be a nice surprise.
At the very least there will be more investors if they like what they see
Bought in today......rest of the week should be interesting
Ok so we have confirmation on financing....so I assume they must have results from another lab....maybe we get the news this week....that would be Very Nice
maybe it was the mm's guess for the close lol